logo
Sign InSign Up

WEST PHARMACEUTICAL SERVICES INC (WST)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for WST, sign up here.

Income Statement

Revenue

$2.9bn

Gross Profit

$1.1bn

Earning before Tax

$715.7m

Net Income

$593.4m

Net Income Common Shareholders

$593.4m

EPS

7.98

Balance Sheet

Cash

$853.9m

Debt

$309.0m

Assets

$3.8bn

Liabilities

$948.5m

Equity

$2.9bn

Enterprise Value

$25.5bn

Cash Flow Statement

Net Cash from Operations

$776.5m

Net Cash from Investing

$-0.4bn

Net Cash from Financing

$-0.5bn

Net Cash Flow

$-40.4m

Free Cash Flow

$414.5m

Free Cash Flow per Share

$5.58

Metrics

Price to Equity

43.91

Price to Equity (Damodaran)

44.13

Price to Book

9.04

Net Margin

0.20

Return on Equity

0.21

Return on Sales

0.25

Get immediate access to 5-years of reference grade data for WST for free.

Sign up

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Company Info

Industry

Medical Instruments & Supplies

Employees

10,700

Address

530 Herman O. West Drive
Exton, PA 19341-0645
United States

Phone

610 594 2900

Last Updated

2024-02-15

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy